NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT02381886 2025-11-10A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsNovartisPhase 1 Active not recruiting166 enrolled
NCT04985604 2025-10-02Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsDay One Biopharmaceuticals, Inc.Phase 2 Terminated23 enrolled 15 charts
NCT07121829 2025-08-14Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsDay One Biopharmaceuticals, Inc.Phase 1 Terminated44 enrolled
NCT04704154 2025-04-18A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid TumorsBayerPhase 2 Completed175 enrolled 20 charts
NCT04430842 2023-01-18Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SQuadriga Biosciences, Inc.Phase 1 Completed15 enrolled
NCT02576665 2020-02-07A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)Tocagen Inc.Phase 1 Terminated21 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts